Antidepressants, benzodiazepines and azapirones for panic disorder in adults: A network meta-analysis

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Giuseppe Guaiana - , Western University (Author)
  • Corrado Barbui - , University of Verona (Author)
  • Deborah M. Caldwell - , University of Bristol (Author)
  • Simon J.C. Davies - , University of Toronto (Author)
  • Toshi A. Furukawa - , Kyoto University (Author)
  • Hissei Imai - , Kyoto University (Author)
  • Markus Koesters - , Ulm University (Author)
  • Aran Tajika - , Kyoto University (Author)
  • Irene Bighelli - , Technical University of Munich (Author)
  • Alessandro Pompoli - (Author)
  • Andrea Cipriani - , Oxford Health NHS Foundation Trust (Author)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

Details

Original languageEnglish
Article numberCD012729
JournalCochrane database of systematic reviews
Volume2017
Issue number7
Publication statusPublished - 31 Jul 2017
Peer-reviewedYes
Externally publishedYes

External IDs

ORCID /0000-0001-7018-6021/work/168207868

Keywords

ASJC Scopus subject areas